نتایج جستجو برای: adjuvant therapy

تعداد نتایج: 682269  

Journal: :dental research journal 0
muhammad shanavas laxmikanth chatra prashanth shenai prasanna kumar rao veena jagathish sreeja prasanna kumar

background: the use of transcutaneous electrical nerve stimulation (tens) in dentistry was fi rstdescribed in 1967, by shane and kessler, but it has yet to gain widespread acceptance in dentistry. a study was undertaken to evaluate the effectiveness of tens therapy as an adjuvant modality and to compare it with the conventional medication in controlling pain in temporomandibular disorder (tmd) ...

Cancer -can significantly have ruining effects on very high of human beings, social, and economic condition. Gastrointestinal (GI) cancer has been reported as one of the most prevalent cancers and the incidence rates of this disorder is increasing across the world. This review explains practical recommendations for the management and improvement of patients with GI cancer by statins. Statins, a...

Cancer -can significantly have ruining effects on very high of human beings, social, and economic condition. Gastrointestinal (GI) cancer has been reported as one of the most prevalent cancers and the incidence rates of this disorder is increasing across the world. This review explains practical recommendations for the management and improvement of patients with GI cancer by statins. Statins, a...

2015
Stefania Gori Alessandro Inno Elena Fiorio Jennifer Foglietta Antonella Ferro Marcella Gulisano Graziella Pinotti Marta Gubiotti Maria Giovanna Cavazzini Monica Turazza Simona Duranti Valeria De Simone Laura Iezzi Giancarlo Bisagni Simon Spazzapan Luigi Cavanna Chiara Saggia Emilio Bria Elisabetta Cretella Patrizia Vici Daniele Santini Alessandra Fabi Ornella Garrone Antonio Frassoldati Laura Amaducci Silvana Saracchini Lucia Evangelisti Sandro Barni Teresa Gamucci Lucia Mentuccia Lucio Laudadio Alessandra Zoboli Fabiana Marchetti Giuseppe Bogina Gianluigi Lunardi Luca Boni Anna Sapino

BACKGROUND The management of pT1a-b pN0 HER2-positive breast cancer is controversial and no data about the efficacy of trastuzumab in this setting are available from randomized clinical trials. The aims of this retrospective study were to assess how patients are managed in clinical practice in Italy, which clinical or biological characteristics influenced the choice of adjuvant systemic therapy...

Journal: :The Ulster Medical Journal 1994
R. H. Wilson R. F. Houston R. J. Moorehead

Survival from colorectal cancer has not improved over the last four decades despite advances in surgery and anaesthesia. The answer to the question whether adjuvant chemotherapy and radiotherapy will improve survival from the disease can only come from randomised, controlled trails. In the future, immunotherapy and gene therapy may be of benefit but these are still many years from the clinical ...

Objective: Organophosphorus compounds (OPs) are common causes of poisonings. Atropine and oximes are pharmacological antidotes of OPs. However, because of their adverse effects and insufficient performance, several other compounds have been evaluated as adjuvant therapy. HESA-A is a herbal-marine drug that contains material from Carum carvi (Persian cumin), Penaeus latisculatus...

Arash Akbarzadeh, Bahman Amani, Fariborz Mokarian, Majid Davari, Mohsen Hoseini, Nastaran Heidarzadeh Khoramabadi,

Background: Trastuzumab in combination with chemotherapy has long been established as a standard treatment for HER2-positive patients in early stage breast cancer (BC). The present study aimed at assessing the effectiveness of trastuzumab adjuvant therapy in early stage BC in overall survival (OS) and disease-free survival (DFS).    Methods: A systematic review and meta-analysis was ...

Journal: :Current Oncology Reports 2017

Journal: :Hematology/Oncology Clinics of North America 2021

2017
Mridula Krishnan Aabra Ahmed Ryan W Walters Peter T Silberstein

BACKGROUND Adjuvant therapy after curative resection is associated with survival benefit in stage III pancreatic cancer. We analyzed the factors affecting the outcome of adjuvant therapy in stage III pancreatic cancer and compared overall survival with different modalities of adjuvant treatment. METHODS This is a retrospective study of patients with stage III pancreatic cancer listed in the N...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید